38378122|t|Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets.
38378122|a|Alzheimer's disease (AD), the most common aging-associated neurodegenerative dementia disorder, is defined by the presence of amyloid beta (Abeta) and tau aggregates in the brain. However, more than half of patients also exhibit aggregates of the protein TDP-43 as a secondary pathology. The presence of TDP-43 pathology in AD is associated with increased tau neuropathology and worsened clinical outcomes in AD patients. Using C. elegans models of mixed pathology in AD, we have previously shown that TDP-43 specifically synergizes with tau but not Abeta, resulting in enhanced neuronal dysfunction, selective neurodegeneration, and increased accumulation of pathological tau. However, cellular responses to co-morbid tau and TDP-43 preceding neurodegeneration have not been characterized. In this study, we evaluate transcriptomic changes at time-points preceding frank neuronal loss using a C. elegans model of tau and TDP-43 co-expression (tau-TDP-43 Tg). We find significant differential expression and exon usage in genes enriched in multiple pathways including lipid metabolism and lysosomal degradation. We note that early changes in tau-TDP-43 Tg resemble changes with tau alone, but a unique expression signature emerges during aging. We test loss-of-function mutations in a subset of tau and TDP-43 responsive genes, identifying new modifiers of neurotoxicity. Characterizing early cellular responses to tau and TDP-43 co-pathology is critical for understanding protective and pathogenic responses to mixed proteinopathies, and an important step in developing therapeutic strategies protecting against pathological tau and TDP-43 in AD.
38378122	29	32	tau	Gene	4137
38378122	37	43	TDP-43	Gene	23435
38378122	60	69	tauopathy	Disease	MESH:D024801
38378122	125	144	Alzheimer's disease	Disease	MESH:D000544
38378122	146	148	AD	Disease	MESH:D000544
38378122	184	219	neurodegenerative dementia disorder	Disease	MESH:D019636
38378122	251	263	amyloid beta	Gene	351
38378122	265	270	Abeta	Gene	351
38378122	276	279	tau	Gene	4137
38378122	332	340	patients	Species	9606
38378122	380	386	TDP-43	Gene	23435
38378122	429	435	TDP-43	Gene	23435
38378122	449	451	AD	Disease	MESH:D000544
38378122	481	484	tau	Gene	4137
38378122	534	536	AD	Disease	MESH:D000544
38378122	537	545	patients	Species	9606
38378122	553	563	C. elegans	Species	328850
38378122	593	595	AD	Disease	MESH:D000544
38378122	627	633	TDP-43	Gene	23435
38378122	663	666	tau	Gene	4137
38378122	675	680	Abeta	Gene	351
38378122	704	724	neuronal dysfunction	Disease	MESH:D009461
38378122	736	753	neurodegeneration	Disease	MESH:D019636
38378122	798	801	tau	Gene	4137
38378122	844	847	tau	Gene	4137
38378122	852	858	TDP-43	Gene	23435
38378122	869	886	neurodegeneration	Disease	MESH:D019636
38378122	997	1010	neuronal loss	Disease	MESH:D009410
38378122	1019	1029	C. elegans	Species	328850
38378122	1039	1042	tau	Gene	4137
38378122	1047	1053	TDP-43	Gene	23435
38378122	1069	1072	tau	Gene	4137
38378122	1073	1079	TDP-43	Gene	23435
38378122	1193	1198	lipid	Chemical	MESH:D008055
38378122	1267	1270	tau	Gene	4137
38378122	1271	1277	TDP-43	Gene	23435
38378122	1303	1306	tau	Gene	4137
38378122	1420	1423	tau	Gene	4137
38378122	1428	1434	TDP-43	Gene	23435
38378122	1482	1495	neurotoxicity	Disease	MESH:D020258
38378122	1540	1543	tau	Gene	4137
38378122	1548	1554	TDP-43	Gene	23435
38378122	1643	1658	proteinopathies	Disease	MESH:D057165
38378122	1751	1754	tau	Gene	4137
38378122	1759	1765	TDP-43	Gene	23435
38378122	1769	1771	AD	Disease	MESH:D000544
38378122	Positive_Correlation	23435	4137
38378122	Positive_Correlation	MESH:D009461	23435
38378122	Association	MESH:D020258	4137
38378122	Association	MESH:D024801	23435
38378122	Association	MESH:D000544	4137
38378122	Association	MESH:D020258	23435
38378122	Association	MESH:D024801	4137
38378122	Association	MESH:D009410	4137
38378122	Association	MESH:D000544	23435
38378122	Association	MESH:D009410	23435
38378122	Positive_Correlation	MESH:D019636	23435

